News

Article

Latvian Government Partners with Pharma in Signing Letter of Intent

The Latvian government and Pharma have signed a letter of intent on June 29, 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia.

The Latvian Ministry of Health, the Latvian Academy of Sciences, the European Association of Pharmaceutical Industries and Associations (EFPIA), and the Association of International Research-based Pharmaceutical Manufacturers (SIFFA) have signed a letter of intent on June 29, 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia.

The government is hoping to promote stable business conditions while improving access to innovative medicines and investments in research. The Ministry of Health and the pharmaceutical industry have agreed on the provision of transparency in the reimbursed medicines system, availability of medicines, result-oriented uptake of medicines, and the industry’s support to ensure the availability of medicines. A working group will be established to develop specific proposals for a step wise collaboration.

The letter of intent underscores the continued efforts of the research-based pharmaceutical industry to forge partnership with governments across Europe to support the sustainability of national health services and increase access to innovative medicines for the benefit of patients.

Source: EFPIA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content